Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[THE SOMATIC MUTATIONS AND ABERRANT METHYLATION AS POTENTIAL GENETIC MARKERS OF URINARY BLADDER CANCER].

Klinicheskaia laboratornaia diagnostika - 1 Feb 2016

Mikhailenko D S, Kushlinskii N E

Abstract excerpt

All around the world, more than 330 thousands cases of bladder cancer are registered annually hence representing actual problem of modern oncology. Still in demand are search and characteristic of new molecular markers of bladder cancer detecting in tumor cells from urinary sediment and having high diagnostic accuracy. The studies of last decade, especially using methods of genome-wide sequencing, permitted to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Class I Phosphatidylinositol 3-Kinases
Share to CpG Islands

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diagnostic Tests, Routine

Share to Epigenesis, Genetic

Share to Phosphatidylinositol 3-Kinases

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Telomerase

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 27455559

Genes

FGFR3
TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[THE SOMATIC MUTATIONS AND ABERRANT METHYLATION AS POTENTIAL GENETIC MARKERS OF URINARY BLADDER CANCER].PMID 27455559Read ↗

[Recent advances in bladder urothelial carcinogenesis].Semantic proximity Read ↗

Bladder Cancer and Genetic Mutations.Semantic proximity Read ↗

[Molecular diagnostics of bladder cancer-practical ramifications].Semantic proximity Read ↗

Analysis of genome-wide mutation profile and establishment of risk signature for prognosis of bladder cancerSemantic proximity Read ↗

Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.Semantic proximity Read ↗

TP53 Mutation for Prediction of Tumor Recurrence and Metastasis in Bladder Cancer PatientsSemantic proximity Read ↗

Alterations of DNA methylome in human bladder cancerSemantic proximity Read ↗

Bladder cancer: molecular determinants of personalized therapy.Semantic proximity Read ↗

Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with HematuriaSemantic proximity Read ↗

Urine Cellular DNA Point Mutation and Methylation as Potential Biomarkers for the Detection of Urothelial CarcinomaSemantic proximity Read ↗

Molecular pathogenesis and diagnostics of bladder cancer.Semantic proximity Read ↗

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.